A Phase I Dose-Escalation Study of IMGN388 in Patients With Solid Tumors

This study is currently recruiting participants.

Study NCT00721669 Information provided by ImmunoGen, Inc.

First Received: July 22, 2008 Last Updated: July 12, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	October 2012
Estimated Primary Completion Date:	May 2012 (Final data collection date for primary outcome measure)